Search
Powered By HealthLine
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Inhaled Corticosteroids Boost Pneumonia Risk in COPD


Related Encyclopedia
 border=
Abdominoplasty
Acoustic Neurinoma
Ankle Sprains
Ankylosing Spondylitis
More...

Related Healthscout Videos
 border=
eFeed: Teaching Toddlers How to Eat
Don't Wait on Your Prostate
Home Remedies: All Natural Antibiotics
E-Cigarettes: Smoke & Mirrors?
More...

Related Animations
 border=
Asthma
Erectile Dysfunction
More...

Related Drug Information
 border=
Advair Diskus
Cialis
Combivent
Flomax
More...

Related News Articles
 border=
Obesity Appears Linked to Pain
Prostate Size May Be Clue to Severity of Cancer
Many Gay Men Would Support 'Home HIV Test': Study
Young Adults Who Quit Smoking Feel Better Quickly
More...


Page:  << Prev | 1 | 2 | 3

Dr. Norman Edelman, chief medical officer of the American Lung Association, noted the benefit of using steroids to treat COPD is still not clear.

"The issue is of importance as combinations of inhaled steroids and long-acting beta agonists are being increasingly marketed and used for COPD," Edelman said. "Advair is the main one now, Symbicort is likely to be approved for COPD by the FDA soon, and I am told another is on the way."

The most reasonable conclusion is that inhaled steroids do indeed increase pneumonia in COPD without increasing death from pneumonia, Edelman said.

Text Continues Below



"On the other hand, the combinations have been shown to decrease exacerbations of COPD and improve function," he said. "In addition, some data actually suggest, but do not prove, that they prolong life."

This study suggests that the beneficial effects of the combinations are due to the long-acting beta agonists -- bronchodilators -- and not the steroids and implies that the way to treat COPD is with these agents alone, Edelman said. "I am sure that we will see more analyses to this point," he added.

COPD is a major health problem worldwide, but researchers have yet to make the kind of progress made in other major causes of death, Edelman said.

"This may be because some have considered it to be a self-inflicted disease -- via cigarette smoking -- and not worthy of study, but that's unfair," he said. "Almost all smokers have been addicted as teenagers by a wealthy and voracious tobacco industry. Thus, more research focused on early detection and reversal of the lung destruction is needed."

More information

The National Heart, Lung and Blood Institute has more on COPD.

Page:  << Prev | 1 | 2 | 3

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 2/9/2009

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake




SOURCES: Sonal Singh, M.D., M.P.H., assistant professor, internal medicine, Wake Forest University Baptist Medical Center, Winston-Salem, N.C.; Norman Edelman, M.D., chief medical officer, American Lung Association, New York City; Katie Neff, spokeswoman, AstraZeneca, Wilmington, Del.; Patty Johnson, spokeswoman, GlaxoSmithKline, Philadelphia; Feb. 9, 2009, Archives of Internal Medicine


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2012. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire